Guided Therapeutics (GTHP) Common Equity (2010 - 2025)
Guided Therapeutics recorded quarterly Common Equity of -$6.0 million in Q4 2025, down 5.26% quarter-over-quarter from -$5.7 million in Q3 2025, and down 22.72% year-over-year from -$7.8 million in Q4 2024.
Guided Therapeutics' Common Equity history runs 16 years deep, the most recent figure standing at -$6.0 million for Q4 2025.
- In Q4 2025, Common Equity fell 22.72% year-over-year to -$6.0 million; the TTM figure through Dec 2025 stood at -$6.0 million (down 22.72% YoY), while the FY2025 annual figure was -$6.0 million, down 22.72% from the prior year.
- Common Equity came in at -$6.0 million for Q4 2025 at Guided Therapeutics, down from -$5.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of -$2.7 million in Q3 2022 to a low of -$8.0 million in Q1 2021.
- A 5-year average of -$5.0 million and a median of -$5.0 million in 2022 frame the typical range for Common Equity.
- Across the five-year window, Common Equity soared 65.78% in 2022 and plunged 40.78% in 2024, its largest moves.
- Guided Therapeutics' Common Equity stood at -$5.4 million in 2021, then jumped by 47.05% to -$2.9 million in 2022, then tumbled by 32.02% to -$3.8 million in 2023, then decreased by 28.46% to -$4.9 million in 2024, then declined by 22.72% to -$6.0 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered -$6.0 million, -$5.7 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.00 Mn |
| Sep 30, 2025 | -5.70 Mn |
| Jun 30, 2025 | -5.47 Mn |
| Mar 31, 2025 | -5.03 Mn |
| Dec 31, 2024 | -4.89 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -4.67 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Sep 30, 2023 | -3.65 Mn |
| Jun 30, 2023 | -3.32 Mn |
| Mar 31, 2023 | -2.86 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Sep 30, 2022 | -2.65 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -4.99 Mn |
| Dec 31, 2021 | -5.45 Mn |
| Sep 30, 2021 | -7.75 Mn |
| Jun 30, 2021 | -7.99 Mn |
| Mar 31, 2021 | -7.99 Mn |
| Dec 31, 2020 | -10.86 Mn |
| Sep 30, 2020 | -13.82 Mn |
| Jun 30, 2020 | -16.42 Mn |
| Mar 31, 2020 | -11.35 Mn |
| Dec 31, 2019 | -16.94 Mn |
| Sep 30, 2019 | -18.02 Mn |
| Jun 30, 2019 | -18.59 Mn |
| Mar 31, 2019 | -16.01 Mn |
| Dec 31, 2018 | -15.82 Mn |
| Sep 30, 2018 | -14.17 Mn |
| Jun 30, 2018 | -14.22 Mn |
| Mar 31, 2018 | -17.94 Mn |
| Dec 31, 2017 | -19.40 Mn |
| Sep 30, 2017 | -12.35 Mn |
| Jun 30, 2017 | -10.35 Mn |
| Mar 31, 2017 | -9.05 Mn |
| Dec 31, 2016 | -9.27 Mn |
| Sep 30, 2016 | -7.31 Mn |
| Jun 30, 2016 | -7.14 Mn |
| Mar 31, 2016 | -5.45 Mn |
| Dec 31, 2015 | -5.56 Mn |
| Sep 30, 2015 | -3.48 Mn |
| Jun 30, 2015 | -2.74 Mn |
| Mar 31, 2015 | -5.02 Mn |
| Dec 31, 2014 | -4.47 Mn |
| Sep 30, 2014 | -3.95 Mn |
| Jun 30, 2014 | -2.49 Mn |
| Mar 31, 2014 | -1.27 Mn |
| Dec 31, 2013 | -107,000.00 |
| Sep 30, 2013 | 522,000.00 |
| Jun 30, 2013 | 1.75 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Dec 31, 2012 | 1.13 Mn |
| Sep 30, 2012 | 2.12 Mn |
| Jun 30, 2012 | 438,000.00 |
| Mar 31, 2012 | 908,000.00 |
| Dec 31, 2011 | 1.58 Mn |
| Jun 30, 2011 | 410,000.00 |
| Dec 31, 2010 | 1.01 Mn |